1st Cell with Synthetic Genome

After a 15-year marathon, researchers have created the first cell controlled by a synthetic genome.

Written byMegan Scudellari
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

After a 15-year marathon, researchers have created the first cell controlled by a synthetic genome, reported online today at Science. The advance, a landmark in synthetic biology, could someday be used to engineer microbes for environmental or medical applications. "This is a very impressive piece," said Jim Collins, a bioengineer at Boston University, who was not involved in the study. The research is a "methodological tour de force," said Collins.

Combining a series of techniques developed since 1995, J. Craig Venter and colleagues at the J. Craig Venter Institute in Rockville, Maryland began with a digitized genome sequence of Mycoplasma mycoides, a fast-growing bacterium with a 1-million-base genome. They ordered the pieces of that genome from a DNA sequence manufacturer, then used yeast to stitch the pieces together into a whole genome. The researchers transferred the synthetic M. mycoides genome into a M. capricolum recipient cell, replacing the native DNA, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies